Dietary Maneuvers to Reduce Production of Colon-Derived Uremic Solutes
NCT ID: NCT01186276
Last Updated: 2022-08-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
58 participants
INTERVENTIONAL
2010-07-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combination of Medium Cut-off Dialyzer Membrane and Diet Modification to Alleviate Residual Uremic Syndrome of Dialysis Patients
NCT04247867
Fiber Intake in an End Stage Renal Disease (ESRD) Population Followed Over 2 Years
NCT00874380
Increasing the Removal of Protein-Bound Solutes During Extended Hours Hemodialysis
NCT01892839
Treatment Modification to Reduce Symptom Burden in Hemodialysis
NCT01775800
Volume,Sodium and Blood Pressure Management in HD
NCT01766882
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* taking a dietary supplement containing either fiber or starch (starch serves as a control for fiber) for six weeks. The fiber dose initially employed will be 30 g/day of high amylose corn and the control starch dose employed will be 30 g/day of waxy corn starch. Supplements which come in dry powder form will be mixed in liquid or food for consumption.
* filling out a food record and a quality of life questionnaire
* keeping a diary of any gi symptoms
* collecting samples of blood, spent dialysate, urine(if the patient still makes urine) and stool.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Corn Starch
Corn starch will serve as the control arm.
Corn starch
Corn starch to be consumed daily for 6 weeks. This will serve as the control/placebo arm.
Fiber
Fiber will serve as the intervention.
Fiber
Dietary fiber supplements to be consumed daily for 6 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fiber
Dietary fiber supplements to be consumed daily for 6 weeks.
Corn starch
Corn starch to be consumed daily for 6 weeks. This will serve as the control/placebo arm.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* recent hospitalization or other event resulting in instability of food intake
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Timothy W Meyer
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Palo Alto Health Care System
Palo Alto, California, United States
Satellite Dialysis
Redwood City, California, United States
SCVMC
San Jose, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cooper TE, Khalid R, Chan S, Craig JC, Hawley CM, Howell M, Johnson DW, Jaure A, Teixeira-Pinto A, Wong G. Synbiotics, prebiotics and probiotics for people with chronic kidney disease. Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIH R21AT005123-01A1
Identifier Type: -
Identifier Source: secondary_id
SU-07292010-6626
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.